Related Experiment Video
Updated: Jun 4, 2026

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
Published on: December 17, 2021
Osmotic capsules: A universal oral, controlled-release drug delivery dosage form
Kenneth C Waterman1, G Scott Goeken, Sanjay Konagurthu
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA.
Abstract:
An osmotic, oral, controlled-release capsule is described. This capsule provides drug delivery at fixed delivery rates (T(80%)=6 or 14h) independent of drug properties (e.g., solubility) or drug loading, thereby allowing rapid development of investigational or commercial drugs, especially for proof-of-concept type clinical studies. The capsule body and cap are prepared with cellulose acetate and polyethylene glycol in acetone and water using high density polyethylene molds as templates and a conventional tablet pan coater. After the shells are removed from the molds manually, a laser hole is drilled in the end of the capsule body. The drug is introduced as a shaped tablet admixed with polyethylene oxide. A "push" tablet consisting of high molecular weight polyethylene oxide, microcrystalline cellulose, and sodium chloride is also inserted into the capsule body. The capsule halves lock together due to ridges, alleviating the need for a banding operation.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Drug Delivery Systems: Introduction
Modified-Release Drug Delivery Systems: Classification
Oral Drug Delivery Systems: Delayed-Release Systems
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Rate-Programmed II

